Cargando…
The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death
ABT-737, a B cell lymphoma-2 (Bcl-2) family inhibitor, activates apoptosis in cancer cells. Arsenic trioxide is an apoptosis activator that impairs cancer cell survival. The aim of this study was to evaluate the effect of a combination treatment with ABT-737 and arsenic trioxide on uterine cervical...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016694/ https://www.ncbi.nlm.nih.gov/pubmed/31906234 http://dx.doi.org/10.3390/cancers12010108 |
_version_ | 1783497034051878912 |
---|---|
author | Hsin, I-Lun Chou, Ying-Hsiang Hung, Wei-Li Ko, Jiunn-Liang Wang, Po-Hui |
author_facet | Hsin, I-Lun Chou, Ying-Hsiang Hung, Wei-Li Ko, Jiunn-Liang Wang, Po-Hui |
author_sort | Hsin, I-Lun |
collection | PubMed |
description | ABT-737, a B cell lymphoma-2 (Bcl-2) family inhibitor, activates apoptosis in cancer cells. Arsenic trioxide is an apoptosis activator that impairs cancer cell survival. The aim of this study was to evaluate the effect of a combination treatment with ABT-737 and arsenic trioxide on uterine cervical cancer cells. MTT (3-(4,5-dimethylthiazol-2-yl)-25-diphenyltetrazolium bromide) assay revealed that ABT-737 and arsenic trioxide induced a synergistic effect on uterine cervical cancer cells. Arsenic trioxide enhanced ABT-737-induced apoptosis and caspase-7 activation and the ABT-737-mediated reduction of anti-apoptotic protein Mcl-1 in Caski cells. Western blot assay revealed that arsenic trioxide promoted the ABT-737-mediated reduction of CDK6 and thymidylate synthetase in Caski cells. Arsenic trioxide promoted ABT-737-inhibited mitochondrial membrane potential and ABT-737-inhibited ANT expression in Caski cells. However, ABT-737-elicited reactive oxygen species were not enhanced by arsenic trioxide. The combined treatment induced an anti-apoptosis autophagy in SiHa cells. This study is the first to demonstrate that a combination treatment with ABT-737 and arsenic trioxide induces a synergistic effect on uterine cervical cancer cells through apoptosis. Our findings provide new insights into uterine cervical cancer treatment. |
format | Online Article Text |
id | pubmed-7016694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70166942020-02-28 The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death Hsin, I-Lun Chou, Ying-Hsiang Hung, Wei-Li Ko, Jiunn-Liang Wang, Po-Hui Cancers (Basel) Article ABT-737, a B cell lymphoma-2 (Bcl-2) family inhibitor, activates apoptosis in cancer cells. Arsenic trioxide is an apoptosis activator that impairs cancer cell survival. The aim of this study was to evaluate the effect of a combination treatment with ABT-737 and arsenic trioxide on uterine cervical cancer cells. MTT (3-(4,5-dimethylthiazol-2-yl)-25-diphenyltetrazolium bromide) assay revealed that ABT-737 and arsenic trioxide induced a synergistic effect on uterine cervical cancer cells. Arsenic trioxide enhanced ABT-737-induced apoptosis and caspase-7 activation and the ABT-737-mediated reduction of anti-apoptotic protein Mcl-1 in Caski cells. Western blot assay revealed that arsenic trioxide promoted the ABT-737-mediated reduction of CDK6 and thymidylate synthetase in Caski cells. Arsenic trioxide promoted ABT-737-inhibited mitochondrial membrane potential and ABT-737-inhibited ANT expression in Caski cells. However, ABT-737-elicited reactive oxygen species were not enhanced by arsenic trioxide. The combined treatment induced an anti-apoptosis autophagy in SiHa cells. This study is the first to demonstrate that a combination treatment with ABT-737 and arsenic trioxide induces a synergistic effect on uterine cervical cancer cells through apoptosis. Our findings provide new insights into uterine cervical cancer treatment. MDPI 2019-12-31 /pmc/articles/PMC7016694/ /pubmed/31906234 http://dx.doi.org/10.3390/cancers12010108 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hsin, I-Lun Chou, Ying-Hsiang Hung, Wei-Li Ko, Jiunn-Liang Wang, Po-Hui The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death |
title | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death |
title_full | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death |
title_fullStr | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death |
title_full_unstemmed | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death |
title_short | The Application of Arsenic Trioxide in Ameliorating ABT-737 Target Therapy on Uterine Cervical Cancer Cells through Unique Pathways in Cell Death |
title_sort | application of arsenic trioxide in ameliorating abt-737 target therapy on uterine cervical cancer cells through unique pathways in cell death |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016694/ https://www.ncbi.nlm.nih.gov/pubmed/31906234 http://dx.doi.org/10.3390/cancers12010108 |
work_keys_str_mv | AT hsinilun theapplicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT chouyinghsiang theapplicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT hungweili theapplicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT kojiunnliang theapplicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT wangpohui theapplicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT hsinilun applicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT chouyinghsiang applicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT hungweili applicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT kojiunnliang applicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath AT wangpohui applicationofarsenictrioxideinamelioratingabt737targettherapyonuterinecervicalcancercellsthroughuniquepathwaysincelldeath |